Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

Efficacy and Safety of Edoxaban in Nonvalvular Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.

Read this article at

ScienceOpenPublisherPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      Edoxaban is a potential alternative to warfarin for preventing thromboembolism in atrial fibrillation. However, the efficacy and safety, and the optimal regimen of edoxaban are still controversial. This study compared the efficacy and safety of edoxaban and warfarin in nonvalvular atrial fibrillation, and the effects of different edoxaban dosages.

      Related collections

      Author and article information

      Affiliations
      [1 ] Department of Cardiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China.
      [2 ] Department of Cardiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China. Electronic address: wanglich@mail.sysu.edu.cn.
      Journal
      J Stroke Cerebrovasc Dis
      Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
      Elsevier BV
      1532-8511
      1052-3057
      Dec 2015
      : 24
      : 12
      26324517 S1052-3057(15)00429-2 10.1016/j.jstrokecerebrovasdis.2015.07.026

      Comments

      Comment on this article